Nvidia Just Made a Major Move for 2026. Time to Buy?

Nvidia, benefiting from surging demand for AI chips, reported revenue up 62% to $57 billion in the latest quarter with gross margins above 70% and fiscal 2025 China sales representing 13% of revenue; the company earlier took a roughly $1 billion charge on unsellable chips due to U.S. export controls. Following a U.S. policy change announced by President Trump, Nvidia plans to begin shipping its H200 to China using existing inventory and has asked TSMC to ramp production against orders for about two million H200 units for 2026, subject to Chinese approval and a requirement to offer 25% of China chip sales to the U.S. The move could materially boost 2026 China revenue but carries execution and regulatory risks as Nvidia balances H200 production with ongoing demand for its newer Blackwell platform.

Analysis

Market structure: Nvidia (NVDA) is the primary beneficiary if H200 shipments to China resume — Reuters’ 2 million-unit order for 2026 implies meaningful demand and could restore up to ~10–13% of FY2025 revenue (China was 13% of revenue). TSMC (TSM) is a secondary winner via foundry volume; U.S. Blackwell demand could face supply trade-offs, constraining incremental share gains for competitors and preserving NVDA’s pricing power and >70% gross margins in the near term.

Risk assessment: Key tail risks are regulatory reversal (U.S. re-tightening or China denial), TSMC capacity shortfalls, or the ‘25% to U.S.’ contractual requirement imposing economic frictions; any of these could wipe out the China upside within 30–60 days. Immediate market moves will be event-driven (days); production and revenue recognition will play out over months (Q2–Q4 2026); durable market-share effects are a multi-year story tied to Blackwell adoption.

Trade implications: Tactical longs on NVDA (2–3% portfolio) with protective hedges make sense: buy 6–9 month call spreads to cap cost and buy 3-month 8–10% OTM puts to limit event risk until China approval; add a smaller 1%–2% TSM position to capture foundry upside. Consider a pair trade: long NVDA / short SOXX (or broad semis) at a 1:0.6 notional ratio to isolate NVDA-specific China reentry upside.

Contrarian angles: Consensus likely underestimates supply-reallocation risk — ramping H200 could cannibalize Blackwell capacity and compress realized ASPs if TSMC prioritizes older nodes. Also the 25% clause and logistical/regulatory approvals create asymmetric downside not fully priced; conversely, if China fully reopens within 60 days, upside could be underpriced by >20–30% as analysts re-rate long-term TAM assumptions.

Key Decisions for Investors

• Establish a 2–3% long position in NVDA ahead of potential China approval; implement a 6–9 month bull call spread (buy 10% ITM call, sell 40% OTM call) to limit premium outlay, and simultaneously buy a 3-month 8% OTM put as event insurance until Chinese regulatory approval is confirmed.
• Add a 1–2% long position in TSM to capture incremental foundry volume tied to H200 production; trim if TSM issues guidance showing >10% incremental capex or if TSM warns of reallocation that delays Blackwell wafers.
• Run a relative-value pair: long NVDA vs short SOXX at a 1:0.6 notional ratio to express Nvidia-specific China upside while hedging broad semiconductor cyclicality; rebalance if NVDA outperforms by >25% or if SOXX underperforms by >15%.
• If China formally approves shipments within 30–60 days, sell 1/3 of NVDA exposure on a +25% move and cover remaining exposure with 9–12 month covered calls to monetize implied volatility; if approval is delayed beyond 60 days, reduce NVDA position by 50% and retain puts for downside protection.